Literature DB >> 30043131

Author's response to: letter to the editor.

Anne Pernille Ofstad1,2, Dan Atar3,4, Lars Gullestad4,5, Gisle Langslet6, Odd Erik Johansen7,8.   

Abstract

Mesh：

Year:  2018        PMID： 30043131     DOI： 10.1007/s10741-018-9728-6

Source DB:  PubMed          Journal:  Heart Fail Rev        ISSN： 1382-4147            Impact factor:   4.214


× No keyword cloud information.
  5 in total

Review 1.  2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.

Authors:  Clyde W Yancy; Mariell Jessup; Biykem Bozkurt; Javed Butler; Donald E Casey; Monica M Colvin; Mark H Drazner; Gerasimos S Filippatos; Gregg C Fonarow; Michael M Givertz; Steven M Hollenberg; JoAnn Lindenfeld; Frederick A Masoudi; Patrick E McBride; Pamela N Peterson; Lynne Warner Stevenson; Cheryl Westlake
Journal:  J Card Fail       Date:  2017-04-28       Impact factor: 5.712

Review 2.  Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies: A Scientific Statement From the American Heart Association.

Authors:  Biykem Bozkurt; Monica Colvin; Jennifer Cook; Leslie T Cooper; Anita Deswal; Gregg C Fonarow; Gary S Francis; Daniel Lenihan; Eldrin F Lewis; Dennis M McNamara; Elfriede Pahl; Ramachandran S Vasan; Kumudha Ramasubbu; Kismet Rasmusson; Jeffrey A Towbin; Clyde Yancy
Journal:  Circulation       Date:  2016-11-03       Impact factor: 29.690

3.  2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.

Authors:  Piotr Ponikowski; Adriaan A Voors; Stefan D Anker; Héctor Bueno; John G F Cleland; Andrew J S Coats; Volkmar Falk; José Ramón González-Juanatey; Veli-Pekka Harjola; Ewa A Jankowska; Mariell Jessup; Cecilia Linde; Petros Nihoyannopoulos; John T Parissis; Burkert Pieske; Jillian P Riley; Giuseppe M C Rosano; Luis M Ruilope; Frank Ruschitzka; Frans H Rutten; Peter van der Meer
Journal:  Eur J Heart Fail       Date:  2016-05-20       Impact factor: 15.534

4.  Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failure.

Authors:  L Gullestad; H Aass; J G Fjeld; L Wikeby; A K Andreassen; H Ihlen; S Simonsen; J Kjekshus; S Nitter-Hauge; T Ueland; E Lien; S S Frøland; P Aukrust
Journal:  Circulation       Date:  2001-01-16       Impact factor: 29.690

5.  Relevant effects of beta1-adrenoceptor autoantibodies in chronic heart failure.

Authors:  Valerie Boivin-Jahns; Roland Jahns; Fritz Boege
Journal:  Front Biosci (Landmark Ed)       Date:  2018-06-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.